NTBC Treatment Monitoring in Chilean Patients with Tyrosinemia Type 1 and Its Association with Biochemical Parameters and Liver Biomarkers

Treatment and follow-up in Hereditary Tyrosinemia type 1 (HT-1) patients require comprehensive clinical and dietary management, which involves drug therapy with NTBC and the laboratory monitoring of parameters, including NTBC levels, succinylacetone (SA), amino acids, and various biomarkers of liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuenzalida, Karen, Leal-Witt, María Jesús, Guerrero, Patricio, Hamilton, Valerie, Salazar, María Florencia, Peñaloza, Felipe, Arias, Carolina, Cornejo, Verónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706240/
https://www.ncbi.nlm.nih.gov/pubmed/34945128
http://dx.doi.org/10.3390/jcm10245832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706240/
https://www.ncbi.nlm.nih.gov/pubmed/34945128
http://dx.doi.org/10.3390/jcm10245832

Ejemplares similares